Viewing Study NCT00338494


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-25 @ 11:38 PM
Study NCT ID: NCT00338494
Status: COMPLETED
Last Update Posted: 2015-01-29
First Post: 2006-06-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Sponsor: Yale University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module